Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

High levels of the seizure medication sodium valproate can cause hair loss.

A liquid protein diet caused hair loss in a young woman.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

64 drugs can cause hair loss, needing better monitoring and updated labels.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.